Continuous versus intermittent antiretroviral treatment among Human Immunodeficiency Virus (HIV)-infected individuals in a gold mining community in South Africa

ISRCTN ISRCTN52488382
DOI https://doi.org/10.1186/ISRCTN52488382
Secondary identifying numbers G0100484
Submission date
18/05/2001
Registration date
18/05/2001
Last edited
13/12/2007
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Alison Grant
Scientific

Clinical Research Unit
London School of Hygiene and Tropical Medicine
Keppel Street
London
WC1E 7HT
United Kingdom

Phone +44 (0)20 7927 2304
Email alison.grant@lshtm.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedHIV, Acquired Immunodeficiency Syndrome (AIDS)
InterventionContinuous versus intermittent antiretroviral treatment. September 2005: the study was never funded and never started.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Antiretrovirals
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2002
Completion date31/12/2002
Reason abandoned (if study stopped)Never funded, never started

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteriaNot provided at time of registration
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2002
Date of final enrolment31/12/2002

Locations

Countries of recruitment

  • England
  • South Africa
  • United Kingdom

Study participating centre

Clinical Research Unit
London
WC1E 7HT
United Kingdom

Sponsor information

Medical Research Council (MRC) (UK)
Research council

20 Park Crescent
London
W1B 1AL
United Kingdom

Phone +44 (0)20 7636 5422
Email clinical.trial@headoffice.mrc.ac.uk
Website http://www.mrc.ac.uk

Funders

Funder type

Research council

Medical Research Council
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan